CRIS Cancer Foundation and the ICR are offering 2-3 year fellowships to support the development of outstanding early ...

A new blood test identifies a key biomarker for Alzheimer’s disease, which may help make assessing the presence and stage of ...

A study involving more than 1,700 people from five hospitals in Barcelona, Sweden and Italy has validated the usefulness of a biomarker in blood to detect Alzheimer's disease in the clinical setting.

In a small study, lactotransferrin (LTF) was identified as a potentially important biomarker in extensive-stage small cell ...

Alzheimer’s blood tests may one day allow patients and their doctors to track their individual progress in reducing risk, ...

Beam Therapeutics Inc. (NASDAQ:BEAM) on Saturday presented additional data from the Phase 1/2 clinical trial of BEAM-302 in ...

Several biomarker tests have been available for over a decade, with extensive research backing their effectiveness. Yet, many ...

Dementia affects millions of people worldwide, causing a serious impact on the economy and the healthcare system. Alzheimer’s ...

Roche outlined how digital health technologies (DHTs) provide more sensitive measures of disease progression in early Parkinson’s disease (PD).

A new study has shown that specific blood biomarkers could predict the onset of dementia, up to ten years before an actual ...

A risk-assessment tool incorporating NT-proBNP and high-sensitivity troponin performs better than clinical scores for predicting stroke ... additional evidence supporting the potential role of ...